Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use STEGLATRO safely and effectively. See full prescribing information for STEGLATRO. STEGLATRO® (ertugliflozin) tablets, for oral useInitial U.S. Approval: 2017
Medication labelWhy this: Advisory · dailymed-prescription
STEGLATRO® is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. Limitations of Use Not recommended for use to improve glycemic control in patients with type 1 diabetes mellitus [see Warnings and Precautions (5.1)].
- generic_name
- ertugliflozin
- product_names
- ertugliflozin
- ndc
- 0006-5363, 0006-5363-03, 0006-5363-08, 0006-5363-09, 0006-5363-06, 0006-5363-07, 0006-5363-10, 0006-5364, 0006-5364-03, 0006-5364-08, 0006-5364-09, 0006-5364-06, 0006-5364-07
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en